check_circleStudy Completed

Mycoses

Bayer Identifier:
Trial_0449
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study to evaluate the efficacy and tolerability of BAY B 5097 500 mg vaginal tablets as single dose or one-day therapy of vaginal yeast infections

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
90
Trial Dates
November 1979 - May 1980
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Open label, mycologically controlled study to evaluate the efficacy and tolerability of BAY B 5097 500 mg vaginal tablets as single dose or one-day therapy of vaginal yeast infections.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.